The business to be sold operates in Europe, Japan, Canada, Australia and New Zealand and includes approximately 3,800 employees Abbott...
Read moreTelmisartan is Glenmark’s generic version of Boehringer Ingelheim’s Micardis Glenmark Generics Inc., US a subsidiary of Glenmark Generics Limited...
Read moreSince the introduction of routine rotavirus vaccination in 2006, rates of diarrhea-related hospitalizations in US children have decreased significantly. ...
Read morePfizer Inc. has announced the election of James C. Smith to its Board of Directors, effective immediately. Mr. Smith also...
Read moreThe US crackdown on healthcare fraud is paying huge dividends to the exchequer, accounting for three quarters of the money...
Read moreOn Friday, June 06, 2014, the NASDAQ Composite ended at 4,321.40, up 0.59%, the Dow Jones Industrial Average finished the...
Read moreUS-based Immune Design has started dosing patients in a Phase I clinical study of LV305, an immuno-oncology investigational agent from...
Read moreUS-based biotechnology firm Edge Therapeutics has started enrolling patients in the second group of a multicenter, randomised, controlled, open-label, Phase...
Read moreUS-based Arena Pharmaceuticals has started dosing patients in an investigational Phase Ib clinical trial of APD334, an oral drug candidate...
Read moreUS-based Boston Therapeutics (BTI) has started a Phase IIb clinical trial SD-002 to evaluate the efficacy and safety of Sugardown...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
